In response to a lawsuit, the FDA has said that it will reevaluate its previous decision to remove tirzepatide from its ...

Providing coverage for weight-loss drugs such as Wegovy and Ozempic is forcing employers to make some critical decisions.

Facing a lawsuit, the Food and Drug Administration has decided to reconsider its decision to take popular weight-loss and diabetes drugs off of the national shortage list, which will allow compounding ...

Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. Food and Drug ...

As debate still rages over HRT, many women are looking for complementary solutions to hormone therapy or alternatives if they ...

Celebrities like Oprah Winfrey are touting it. People are microdosing it. And, in the midst of a national shortage of key ...

UNEMPLOYED Brits could be given free weight-loss jabs under plans being drawn up by Wes Streeting. The Health Secretary wants ...

For millions of Americans wondering about the best way to quit smoking, the journey can feel daunting.  Nicotine changes the ...

For everything from GLP-1 and cancer costs to provider networks, one employer association has strategies — and they don't ...

As prices for Ozempic have risen in recent months, many people may be seeking cheaper alternatives for managing diabetes or weight loss. Dr. Brett Osborn and Dr. Sue Decotiis warn of potential risks.

If Medicare were to start covering popular weight loss drugs such as Wegovy and Zepbound, it could increase federal spending ...

The changes coming with the new year — including a lower cap on out-of-pocket prescription-drug costs and a new program designed to help enrollees spread out their medication costs over the ...